Brief: Trilink Biotechnologies Announces Manufacturing Capabilities Expansion As mRNA Manufacturing Facility Nears Completion
24/05/2023 13:41
May 24 (Reuters) - Maravai LifeSciences Holdings Inc
MRVI.O :
* TRILINK BIOTECHNOLOGIES® ANNOUNCES MANUFACTURING
CAPABILITIES
EXPANSION AS MRNA MANUFACTURING FACILITY NEARS COMPLETION
Source text for Eikon: ID:nBw5bB2qBa
Further company coverage: MRVI.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Maravai Lifesciences Holdings
See all newsMaravai LifeSciences Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Maravai LifeSciences Q2 revenue beats estimates on strong TriLink demand
Maravai LifeSciences Holdings Inc expected to post a loss of 4 cents a share - Earnings Preview
Maravai LifeSciences Q1 revenue rises on higher CleanCap sales
Brief: Maravai LifeSciences Q1 Revenue USD 65.8 Million Vs. IBES Estimate USD 53 Million